HIGH

High-Risk Antibiotic Recall: Sulfamethoxazole and Trimethoprim 800/160 mg Double Strength Packets Re

A high-risk recall of sulfamethoxazole and trimethoprim 800 mg/160 mg double-strength tablets is active nationwide in the United States. The Harvard Drug Group and distribution partners have halted use of a lot due to a foreign-substance finding in packaging material. No tablets tested positive for micro-organisms. Consumers should stop using the product and consult their healthcare providers.

Quick Facts at a Glance

Recall Date
September 2, 2025
Hazard Level
HIGH
Brands
SULFAMETHOXAZOLE AND TRIMETHOPRIM, Cardinal Health, Major Pharmaceuticals
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT

Hazard Information

Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

This antibiotic combines sulfamethoxazole and trimethoprim for bacterial infections. It is used under medical supervision and is distributed nationwide.

Why This Is Dangerous

A foreign-substance material in packaging raises contamination concerns. No tablets were contaminated.

Industry Context

This recall is not part of a broader industry recall pattern.

Real-World Impact

Immediate stop-use is required; potential supply disruption for patients needing antibiotics.

Practical Guidance

How to identify if yours is affected

  1. Check outer bag NDC 55154-7895-0
  2. Check inner blister NDC 0904-2725-61
  3. Look for lot N02309 on tablets or packaging
  4. Bag IDs N02309A/N02309B
  5. Verify packaging material vs tablets

Where to find product info

FDA enforcement recall page D-0625-2025 and FDA enforcement report with recall number D-0625-2025

What timeline to expect

Remedy delivery via recall notification letters; refunds/replacements governed by distributor policies

If the manufacturer is unresponsive

  • Document communications
  • Escalate to FDA recall contact
  • Consider consumer protection agencies if needed

How to prevent similar issues

  • Use authentic suppliers
  • Verify lot numbers before distribution
  • Maintain packaging integrity checks on received medicines

Documentation advice

Keep recall notice, take photos of packaging and lot numbers, note dates of receipt

Product Details

Product: Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg double strength, 10 tablets per blister pack (10x1) per bag. Distributors: The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories. Distributed by Cardinal Health, Dublin, OH 43017. NDC: 55154-7895-0. Outer bag contains NDC 0904-2725-61 in inner blisters. Lot: N02309. Bag identifiers: Bag N02309A and N02309B.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • Nationwide distribution in the USA
  • Active recall dated 2025-09-02
  • High hazard level
  • Lot N02309 with bag identifiers N02309A/N02309B
  • Inner blister lot N02309
  • NDC 55154-7895-0 outer bag; inner NDC 0904-2725-61

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANT
Injury Types
POISONINGELECTRICAL

Product Classification

Product Details

Model Numbers
Bag: N02309A
Bag: N02309B
Inner blister: Lot N02309
UPC Codes
55154-7895
0904-2725
55154-7895-0
+1 more
Affected States
ALL
Report Date
September 17, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
HIGH

LEADER Ultra Lubricating Eye Drops Recalled for Sterility Issue (2026)

Cardinal Health distributed LEADER Ultra Lubricating Eye Drops and related store-brand lubricating eye drops nationwide. The recall cites a lack of assurance of sterility. Consumers should stop using these products immediately and contact KC Pharmaceuticals for guidance.

LEADER ULTRA LUBRICATING EYE DROPS
Lack of
Read more
Health & Personal Care
HIGH

Leader Artificial Tears Recalled 589,848 Bottles for Sterility Issue in 2026

Leader Artificial Tears Sterile Lubricant Eye Drops sold nationwide are recalled due to lack of assurance of sterility. The recall involves multiple store-brand lines distributed by Cardinal Health and others. Consumers should stop using the product immediately and follow recall guidance from KC Pharmaceuticals via email.

Leader
Lack of
Read more
Health & Personal Care
HIGH

Medline Chest Drainage Units Recall Updated IFUs for Adults 18+

Medline Industries recalls 2,894 Aqua-Seal Chest Drainage Units from Cardinal Health after updating IFUs to specify adult patients 18 years and older. The devices were distributed worldwide, including California, Chile and Panama. The update clarifies intended patient population and requires action from healthcare providers to stop use until further notice.

Medline Industries, LP
The instructions
Read more
Health & Personal Care
HIGH

Major Pharmaceuticals Gabapentin 100 mg 10-Capsule Recall Nationwide 2025

Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, 10 capsules per blister pack, distributed nationwide in the United States. The recall cites failed impurities and degradation specifications from routine stability testing, specifically an out-of-spec Highest Unknown Impurity. Consumers and healthcare providers should stop using this product immediately and contact The Harvard Drug集团

Gabapentin
Failed Impurities/Degradation
Read more
Health & Personal Care
HIGH

Gabapentin 100 mg Capsules Recalled by Major Pharmaceuticals in 2025, 100-Count Pack

Major Pharmaceuticals recalled Gabapentin capsules, 100 mg, 100-count, distributed nationwide in the United States. The recall stems from an out-of-spec highest unknown impurity found during stability testing. Healthcare providers and patients should stop using the product and contact The Harvard Drug Group LLC for guidance.

Gabapentin
Failed Impurities/Degradation
Read more
Health & Personal Care
HIGH

Cardinal Health 200 Salem Sump Anti-Reflux Valve Recalled for Breakage Risk (2025)

Cardinal Health 200, LLC recalls all lots of the Salem Sump Anti-Reflux Valve worldwide after complaints of valve breakage. The recall covers CE-marked valves with multiple identifiers. Hospitals and clinicians should stop using the device immediately and follow manufacturer instructions. This notice alerts providers to check for the affected code and act now.

Cardinal Health
Firm has
Read more
Health & Personal Care
HIGH

Major Pharmaceuticals Chlorpromazine 25 mg Tablets Recalled for Nitrosamine Contamination (1256 Bls,

Major Pharmaceuticals recalled 1,256 blister packs of Chlorpromazine Hydrochloride tablets, 25 mg, sold nationwide in the United States. A CGMP deviation led to the presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake. Healthcare providers and patients should stop using the product and contact Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories for next-步

Chlorpromazine Hydrochloride
CGMP Deviations:
Read more